Transdermal medication system for isosorbide dinitrate

Details Transdermal medication system for isosorbide dinitrate Transdermal medication system for isosorbide dinitrate

A - Human Necessities

61

K

167/245

A61K 31/04 (2006.01) A61K 9/70 (2006.01) A61K 31/34 (2006.01) A61K 47/00 (2006.01)

Patent

CA 1118351

Abstract A pharmaceutical preparation containing isosorbide dinitrate as active ingredient, a solvent, an ointment consistency agent, optionally an emulsifiying agent, water and optionally usual preservatives, antioxidants, pH regulators and/or fragrances. The weight ratio of water to consistency agent (including any emulsifying agent) to solvent is from 30 to 80 : 3 to 35 : 3 to 35. The content of emulsifying agent if present is from 0.5 to 15% by weight based on the preparation and the content of isosorbide dinitrate is from 2 to 20% by weight. The preparation affords a high resorption rate and a more lasting effect on topical administration.

347486

Affiliated with

Also associated with

Rating

Transdermal medication system for isosorbide dinitrate does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transdermal medication system for isosorbide dinitrate, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal medication system for isosorbide dinitrate will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1130848